Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
New York University Child Study Center, New York, NY 10016, USA.
Lawrence
L
Young
Barbara J
BJ
Coffey
D000293:Adolescent; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced* / Q000150:complications; D008297:Male; D020258:Neurotoxicity Syndromes / Q000150:complications; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use*
D018692:Antimanic Agents; D014635:Valproic Acid